Moisand Fitzgerald Tamayo’s Regeneron Pharmaceuticals REGN Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.37K	Hold	7	–	–	﹤0.01%	450
2026 Q1	$5.41K	Hold	7	–	–	﹤0.01%	398
2025 Q4	$5.4K	Sell	7 -6	-46%	-$4.08K	﹤0.01%	401
2025 Q3	$7.31K	Hold	13	–	–	﹤0.01%	391
2025 Q2	$6.83K	Hold	13	–	–	﹤0.01%	384
2025 Q1	$8.24K	Hold	13	–	–	﹤0.01%	364
2024 Q4	$9.26K	Hold	13	–	–	﹤0.01%	352
2024 Q3	$13.7K	Hold	13	–	–	﹤0.01%	324
2024 Q2	$13.7K	Hold	13	–	–	﹤0.01%	281
2024 Q1	$12.5K	Hold	13	–	–	﹤0.01%	293
2023 Q4	$11.4K	Hold	13	–	–	﹤0.01%	322
2023 Q3	$10.7K	Hold	13	–	–	﹤0.01%	331
2023 Q2	$9.34K	Hold	13	–	–	﹤0.01%	327
2023 Q1	$10.7K	Hold	13	–	–	﹤0.01%	324
2022 Q4	$9.38K	Buy	13 +7	+117%	+$5.17K	﹤0.01%	326
2022 Q3	$4K	Buy	+6	New	+$3.78K	﹤0.01%	410
2017 Q4	–	Sell	-5	Closed	-$2K	–	309
2017 Q3	$2K	Buy	+5	New	+$2.38K	﹤0.01%	284

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Moisand Fitzgerald Tamayo's REGN Position: Q2 2026 in Review

Moisand Fitzgerald Tamayo held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 7 shares worth $4.37K. The position accounts for ﹤0.01% of the portfolio, ranked #450.

Moisand Fitzgerald Tamayo first reported a position in REGN in Q3 2017 and has held it in 17 quarters since. The position peaked at $13.7K in Q3 2024. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Moisand Fitzgerald Tamayo held 7 shares of Regeneron Pharmaceuticals worth $4.37K as of Q2 2026.
Moisand Fitzgerald Tamayo left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up ﹤0.01% of Moisand Fitzgerald Tamayo's portfolio in Q2 2026, its #450 holding.
Moisand Fitzgerald Tamayo first reported a position in Regeneron Pharmaceuticals in Q3 2017 and has held it in 17 quarters since.
Moisand Fitzgerald Tamayo's Regeneron Pharmaceuticals position peaked at $13.7K in Q3 2024.
334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q2 2026, filed 13 Jul 2026.